BackNeuroOne Medical Technologies Overview

NeuroOne Medical Technologies Receivables

Latest receivables for NMTC: $1.1M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.10M

Peer trimmed avg / median

Loading

NeuroOne Medical Technologies Receivables History

Loading

NeuroOne Medical Technologies vs. peers: Receivables Comparison

Loading

NeuroOne Medical Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NeuroOne Medical Technologies (NMTC) FAQ

NeuroOne Medical Technologies posts a receivables of $1.1M as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, NeuroOne Medical Technologies's receivables was $0. The latest reading is $1.1M (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of NeuroOne Medical Technologies's financial statement story. At $1.1M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NMTC's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NeuroOne Medical Technologies's other metric pages and overview cover the third.